Bioventus Inc’s filing revealed that its Director Bartholdson John A. acquired Company’s shares for reported $0.68 million on Aug 16 ’24. In the deal valued at $8.55 per share,80,000 shares were bought. As a result of this transaction, Bartholdson John A. now holds 6,913,857 shares worth roughly $56.69 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Bartholdson John A. bought 25,500 shares, generating $217,966 in total proceeds. Upon buying the shares at $8.55, the Director now owns 6,939,357 shares.
Before that, Singleton Mark Leonard sold 9,219 shares. Bioventus Inc shares valued at $51,350 were divested by the SVP & CFO at a price of $5.57 per share. As a result of the transaction, Singleton Mark Leonard now holds 84,895 shares, worth roughly $0.7 million.
Canaccord Genuity upgraded its Bioventus Inc [BVS] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Craig Hallum’s analysts, who increased its forecast for the stock in early August from “a Hold” to “a Buy”. Craig Hallum also remained covering BVS and has decreased its forecast on November 22, 2022 with a “Hold” recommendation from previously “Buy” rating. JP Morgan revised its rating on November 09, 2022. It rated BVS as “an Underweight” which previously was an “an Overweight”.
Price Performance Review of BVS
On Tuesday, Bioventus Inc [NASDAQ:BVS] saw its stock jump 2.50% to $8.20. Over the last five days, the stock has gained 3.80%. Bioventus Inc shares have risen nearly 55.60% since the year began. Nevertheless, the stocks have risen 87.21% over the past one year. While a 52-week high of $8.68 was reached on 08/19/24, a 52-week low of $2.82 was recorded on 04/30/24. SMA at 50 days reached $6.80, while 200 days put it at $5.38.
Levels Of Support And Resistance For BVS Stock
The 24-hour chart illustrates a support level at 7.88, which if violated will result in even more drops to 7.56. On the upside, there is a resistance level at 8.40. A further resistance level may holdings at 8.59. The Relative Strength Index (RSI) on the 14-day chart is 59.81, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.63, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 19.36%. Stochastics%K at 84.41% indicates the stock is a selling.
How much short interest is there in Bioventus Inc?
A steep rise in short interest was recorded in Bioventus Inc stocks on 2024-07-31, growing by 1.1 million shares to a total of 1.73 million shares. Yahoo Finance data shows the prior-month short interest on 2024-06-28 was 0.62 million shares. There was a rise of 63.88%, which implies that there is a positive sentiment for the stock.
